With key long COVID trials yet to yield results, people with the condition are trying to change how clinical trials are done. When Lisa McCorkell got COVID-19 in March 2020, her symptoms were mild. Her physicians told her to isolate from others and that she would recover in a few weeks. But the weeks stretched […]
by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than […]
Sara Novak, January 25, 2024 With a number of large-scale clinical trials underway and researchers on the hunt for new therapies, long COVID scientists are hopeful that this is the year patients — and doctors who care for them — will finally see improvements in treating their symptoms. Here are five bold predictions — all […]
By Deep Shukla on January 28, 2024 Medical News Today Approximately 10%-20%Trusted Source of individuals with a SARS-CoV-2 infection experience lingering symptoms beyond three months after symptom onset. These symptoms referred to as long COVID, can be debilitating, but there is a lack of diagnostic or therapeutic tools. A new study published in Science found that patients experiencing long COVID symptoms six months after […]
By ELLEN GOLDBAUM Published January 11, 2023 “I just kept hearing the same story: that within days they were noticing satisfactory benefit. ” Thomas J. Guttuso Jr., professor, Department of Neurology, University of Buffalo Adults experiencing long COVID may be interested in a new University at Buffalo clinical trial that is testing low-dose lithium as a potential treatment. […]
Carlos Spuch, 1 ,* † Marta López-García, 1 , 2 , † Tania Rivera-Baltanás, 1 , , et.al. Front Pharmacol. 2022; 13: 850583. Published online 2022 Apr 14. doi: 10.3389/fphar.2022.850583PMCID: PMC9046673PMID: 35496309 Abstract At the beginning of the pandemic, we observed that lithium carbonate had a positive effect on the recovery of severely ill patients with COVID-19. Lithium is able to inhibit the replication of several types of […]
By XANTHA LEATHAM, DEPUTY SCIENCE EDITOR FOR THE DAILY MAIL PUBLISHED: 09:51 EST, 4 March 2024 | UPDATED: 12:03 EST, 4 March 2024 Experts may have found the cause of long Covid after discovering that low iron levels following an infection could be a key trigger. An estimated 1.9 million people in the UK alone say they experience symptoms of […]
MAR 01, 2024 – Authored by Marina Zhang via The Epoch Times Dr. Clarice Saba, an otorhinolaryngologist in Brazil, developed sudden hearing loss in her right ear a week after receiving her first dose of the COVID-19 adenovirus vaccine. “I did all the exams and could not find any other reason other than because of […]
by Jason Gale Feb 20, 2024 Microsoft Start (Bloomberg) — Vaccines that protect against severe illness, death and lingering long Covid symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions in the largest global vaccine safety study to date. The rare events — identified early in the pandemic — included a higher […]
Jessica Rose, Nicolas Hulscher https://orcid.org/0009-0008-0677-7386 nichulscher@gmail.com, and Peter A. McCulloughView all authors and affiliations, https://doi.org/10.1177/20420986241226566 Abstract Background: Following the roll-out of the Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, and Janssen Ad26.COV2.S coronavirus disease 2019 (COVID-19) injections in the United States, millions of individuals have reported adverse events (AEs) using the vaccine adverse events reports system (VAERS). The objective of this analysis is to describe […]
